Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents

An experimental bivalent meningococcal outer membrane vesicle (OMV) vaccine (B:4:P1.19,15 and B:4:P1.7-2,4) has been developed to provide wide vaccine coverage particularly of the circulating strains in Europe. A randomized, controlled phase II study (study identification number, 710158/002; Clinica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boutriau, Dominique, Poolman, Jan, Borrow, Ray, Findlow, Jamie, Domingo, Javier Diez, Puig-Barbera, Joan, Baldó, José María, Planelles, Victoria, Jubert, Angels, Colomer, Julia, Gil, Angel, Levie, Karin, Kervyn, Anne-Diane, Weynants, Vincent, Dominguez, Francisco, Barberá, Ramon, Sotolongo, Franklin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1797715/
https://ncbi.nlm.nih.gov/pubmed/17065257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00230-06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados